Supply Chain | 14 December 2022
BSV receives exclusive marketing and distribution right for NexoBrid in India
To focus on providing safer burn treatments for women and armed forces
To focus on providing safer burn treatments for women and armed forces
Ties up with Denmark’s Vestfrost Solutions, to cater to the unique needs of the Indian market
New material distribution will serve medical device and pharmaceutical packaging manufacturers.
The reliability of their products, evidenced by their inclusion in the WHO emergency use list, has further improved with the addition of Takara Bio's enzymes.
The MOU provides for assistance in the form of efficient working Capital Management, development and commercialisation of new products, logistic supply chain management support etc.
Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
Upgrades and global expansion provide additional control, visibility, reliability and recovery for patient-critical, time-and temperature-sensitive products
Cellutions BioStorage is a comprehensive biomaterial storage and logistics company with a vision to leverage advanced technologies to serve biopharmaceutical companies
To strengthen the integrated human-centric preventive health screening ‘Phygital’ ecosystem in India
Becomes first Japanese logistics company to collaborate with EMBALL’ISO, which has a proven track record in vaccine transport
Becomes the first airline globally to develop and launch sustainable, temperature-controlled containers for the transportation of pharmaceuticals
Nippon Express has provided a pharmaceutical distribution platform with strict temperature control in two ranges -- 2 C to 8 C
Facility features LED lighting, solar panels, automation and innovative temperature-controlled systems to maximize efficiency and minimize environmental impact
The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights how blockchain ensures the authenticity of products thereby, improves trust, traceability, and transparency across key sectors
Risk management plans can serve as a safeguard, helping manufacturers prepare for and respond to hazards that could lead to drug supply disruptions and shortages
Recognition illustrates Takeda’s patient-centricity throughout its manufacturing and supply processes
Internationally accepted pharmaceutical GDP regulations stipulate that distributors of pharmaceutical products and warehouses must align their operations with the specified standards
PSCI, a global non-profit organization, works with its members to ensure a positive environment that can improve global healthcare supply chains
The facility will cater to the storage, handling and transportation of pharma, dairy products seafood among others
By connecting a leading LongBio VC to the DeSci (decentralized science) movement, this partnership is a major milestone for the greater decentralized ecosystem
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)
